Envoy Medical Inc.

1.46
0.01 (0.69%)
At close: Apr 24, 2025, 3:59 PM
1.46
0.00%
After-hours: Apr 24, 2025, 04:00 PM EDT

Envoy Medical Statistics

Share Statistics

Envoy Medical has 21.33M shares outstanding. The number of shares has increased by 8.64% in one year.

Shares Outstanding 21.33M
Shares Change (YoY) 8.64%
Shares Change (QoQ) 5.18%
Owned by Institutions (%) n/a
Shares Floating 10.09M
Failed to Deliver (FTD) Shares 5.23K
FTD / Avg. Volume 27.09%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

The PE ratio is -1.29 and the forward PE ratio is -2.46. Envoy Medical's PEG ratio is 0.03.

PE Ratio -1.29
Forward PE -2.46
PS Ratio 119.42
Forward PS 1.3
PB Ratio -1.43
P/FCF Ratio -1.42
PEG Ratio 0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Envoy Medical.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of -0.05.

Current Ratio 1.24
Quick Ratio 1.02
Debt / Equity -0.05
Debt / EBITDA -0.05
Debt / FCF -0.05
Interest Coverage -23.6

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $5.36K
Profits Per Employee $-495.12K
Employee Count 42
Asset Turnover 0.02
Inventory Turnover 0.43

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -71.15% in the last 52 weeks. The beta is 2.33, so Envoy Medical's price volatility has been higher than the market average.

Beta 2.33
52-Week Price Change -71.15%
50-Day Moving Average 1.39
200-Day Moving Average 2.09
Relative Strength Index (RSI) 58.42
Average Volume (20 Days) 19.3K

Income Statement

In the last 12 months, Envoy Medical had revenue of 225K and earned -20.8M in profits. Earnings per share was -1.49.

Revenue 225K
Gross Profit -517K
Operating Income -19.26M
Net Income -20.8M
EBITDA -19.81M
EBIT -19.98M
Earnings Per Share (EPS) -1.49
Full Income Statement

Balance Sheet

The company has 5.48M in cash and 945K in debt, giving a net cash position of 4.54M.

Cash & Cash Equivalents 5.48M
Total Debt 945K
Net Cash 4.54M
Retained Earnings -284.73M
Total Assets 11.54M
Working Capital 1.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.95M and capital expenditures -980K, giving a free cash flow of -18.93M.

Operating Cash Flow -17.95M
Capital Expenditures -980K
Free Cash Flow -18.93M
FCF Per Share -1.01
Full Cash Flow Statement

Margins

Gross margin is -229.78%, with operating and profit margins of -8558.22% and -9242.22%.

Gross Margin -229.78%
Operating Margin -8558.22%
Pretax Margin -9242.22%
Profit Margin -9242.22%
EBITDA Margin -8802.67%
EBIT Margin -8558.22%
FCF Margin -8412.89%

Dividends & Yields

COCH does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for COCH is $9.12, which is 524.7% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.12
Price Target Difference 524.7%
Analyst Consensus Strong Buy
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -39.46
Piotroski F-Score 4